NATIONAL POST
Tilray Is First Canadian Company to Import Medical Pot to U.S.
No Shock Here. Best IPO of 2018 is a two-month-old B.C. pot purveyor
Tilray IPO Blazed a Trail Few Other Cannabis Companies Will Follow
Top Cannabis Exec: Expect to See More Strategic Investment Coming to Cannabis
Cannabis Firm Tilray Revenue Almost Doubles, Shares Climb
Tilray Share Price Rockets Upward After Company's Cannabis Selected by Nova Scotia Liquor Corporation
‘It’s life changing’: Mom credits new cannabis oil study with helping daughter's epilepsy
THC-containing cannabis oil shows promise for treating Dravet Syndrome epilepsy
BC cannabis producer Tilray files for IPO
Tilray IPO: Five things to know about the first pot company to go public on Nasdaq
Tilray Announces Potential Pricing for IPO
Tilray aims for $1.5-billion valuation ahead of planned Nasdaq IPO
Marijuana Stocks: Tilray Set To Become First U.S. Marijuana IPO
INVESTOR’S BUSINESS DAILY
This year, the first two straight-up marijuana stocks joined the New York Stock Exchange and the Nasdaq.
Tilray Inc. Launches Initial Public Offering
Tilray Inc. announced it has launched an IPO of its Class 2 common stock pursuant to a registration statement on Form S-1 previously filed with the United States Securities and Exchange Commission.
Tilray Inc. Announces Filing of a U.S. Registration Statement and Application for Proposed IPO on Nasdaq
Tilray Inc., a vertically-integrated and federally-licensed cannabis cultivator, processor and distributor, today
Big Pharma's first foray into cannabis arrives with Sandoz-Tilray deal
FINANCIAL POST
The partnership signals the first deal between a major pharmaceutical company and a Canadian cannabis producer.
Cannabis producer Tilray taps private equity funding
THE GLOBE AND MAIL
Tilray has raised $60-million to expand its growing capacity in Canada and Europe and to push its brand of medical cannabis products into a handful of new countries.
CBC: Canadian producers set sights on global domination
CBC NEWS
Following Germany, several other European countries, including Greece, Italy, Poland and the Czech Republic, passed new medical cannabis laws. That's led Tilray to begin construction of a $30-million production facility in Portugal to help supply the growing market.
CEO Brendan Kennedy appears on CBC's "On the Money"
CBC NEWS
Tilray Chief Executive Officer Brendan Kennedy discusses Tilray's Portugal expansion with CBC Business News.